{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T12:30:44Z","timestamp":1790944244294,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","valueinhealthjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.jval.2025.01.005","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:55:55Z","timestamp":1737996955000},"page":"591-598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Comparison of the Performance of 6 Surrogacy Models, Including Weighted Linear Regression, Meta-Regression, and Bivariate Meta-Analysis"],"prefix":"10.1016","volume":"28","author":[{"given":"Adrian D.","family":"Vickers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2025.01.005_bib1","author":"Bujkiewicz"},{"issue":"4","key":"10.1016\/j.jval.2025.01.005_bib2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/0272989X21994553","article-title":"Validity of surrogate endpoints and their impact on coverage recommendations: a retrospective analysis across international health technology assessment agencies","volume":"41","author":"Ciani","year":"2021","journal-title":"Med Decis Mak"},{"issue":"4","key":"10.1016\/j.jval.2025.01.005_bib3","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/sim.4780080407","article-title":"Surrogate endpoints in clinical trials: definitions and operational criteria","volume":"8","author":"Prentice","year":"1989","journal-title":"Stat Med"},{"issue":"2","key":"10.1016\/j.jval.2025.01.005_bib4","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/sim.4780110204","article-title":"Statistical validation of intermediate endpoints for chronic disease","volume":"11","author":"Freedman","year":"1992","journal-title":"Stat Med"},{"issue":"5","key":"10.1016\/j.jval.2025.01.005_bib5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/0962280207081864","article-title":"Individual- and trial-level surrogacy in colorectal cancer","volume":"17","author":"Buyse","year":"2008","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.jval.2025.01.005_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/biom.13453","article-title":"Nonparametric estimation of Spearman\u2019s rank correlation with bivariate survival data","volume":"78","author":"Eden","year":"2022","journal-title":"Biometrics"},{"issue":"27","key":"10.1016\/j.jval.2025.01.005_bib7","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1002\/sim.5874","article-title":"Estimating the correlation of bivariate failure times under censoring","volume":"32","author":"Schemper","year":"2013","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.jval.2025.01.005_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/biostatistics\/1.1.49","article-title":"The validation of surrogate endpoints in meta-analyses of randomized experiments","volume":"1","author":"Buyse","year":"2000","journal-title":"Biostatistics"},{"issue":"1","key":"10.1016\/j.jval.2025.01.005_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz002","article-title":"A\u00a0systematic review and recommendation for reporting of surrogate endpoint evaluation using meta-analyses","volume":"3","author":"Xie","year":"2019","journal-title":"JNCI Cancer Spectr"},{"issue":"3","key":"10.1016\/j.jval.2025.01.005_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pst.207","article-title":"Surrogate threshold effect: an alternative measure for meta-analytic surrogate endpoint validation","volume":"5","author":"Burzykowski","year":"2006","journal-title":"Pharm Stat"},{"key":"10.1016\/j.jval.2025.01.005_bib11","series-title":"Measurement Error Models","author":"Fuller","year":"2006"},{"issue":"5","key":"10.1016\/j.jval.2025.01.005_bib12","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1177\/0962280215597260","article-title":"Uncertainty in the Bayesian meta-analysis of normally distributed surrogate endpoints","volume":"26","author":"Bujkiewicz","year":"2017","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"10.1016\/j.jval.2025.01.005_bib13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1037\/0033-2909.93.2.388","article-title":"A\u00a0random-effects model for effect sizes","volume":"93","author":"Hedges","year":"1983","journal-title":"Psychol Bull"},{"issue":"1","key":"10.1016\/j.jval.2025.01.005_bib14","first-page":"116","article-title":"Recommendations about estimating errors-in-variables regression in Stata","volume":"20","author":"Lockwood","year":"2020","journal-title":"Stata"},{"issue":"17","key":"10.1016\/j.jval.2025.01.005_bib15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1002\/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M","article-title":"Meta-analysis for the evaluation of potential surrogate markers","volume":"16","author":"Daniels","year":"1997","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2025.01.005_bib16","series-title":"An Introduction to Statistical Learning With Applications in R","author":"James","year":"2013"},{"key":"10.1016\/j.jval.2025.01.005_bib18","author":"Plummer"},{"issue":"1","key":"10.1016\/j.jval.2025.01.005_bib19","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1186\/s12885-019-5569-5","article-title":"Relative efficacy of interventions in the treatment of second-line non-small cell lung cancer: a systematic review and network meta-analysis","volume":"19","author":"Vickers","year":"2019","journal-title":"BMC Cancer"},{"issue":"21","key":"10.1016\/j.jval.2025.01.005_bib20","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1093\/jnci\/djt270","article-title":"Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: a meta-analysis","volume":"105","author":"Oba","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.jval.2025.01.005_bib21","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor Package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Soft"},{"issue":"1","key":"10.1016\/j.jval.2025.01.005_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1467-985X.2008.00552.x","article-title":"A\u00a0re-evaluation of random-effects meta-analysis","volume":"172","author":"Higgins","year":"2009","journal-title":"J\u00a0R Stat Soc A"},{"key":"10.1016\/j.jval.2025.01.005_bib23","series-title":"Network Meta-analysis for Decision-making","author":"Dias","year":"2018"},{"issue":"6","key":"10.1016\/j.jval.2025.01.005_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/sim.6381","article-title":"Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis","volume":"34","author":"Turner","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jval.2025.01.005_bib25","author":"Sikali"},{"key":"10.1016\/j.jval.2025.01.005_bib26","author":"Signorell"},{"key":"10.1016\/j.jval.2025.01.005_bib27","series-title":"Survey Sampling","author":"Kish","year":"1965"},{"issue":"9","key":"10.1016\/j.jval.2025.01.005_bib28","first-page":"1","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"26","key":"10.1016\/j.jval.2025.01.005_bib29","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.1002\/sim.9886","article-title":"Handling missing within-study correlations in the evaluation of surrogate endpoints","volume":"42","author":"Collier","year":"2023","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.jval.2025.01.005_bib30","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41416-020-01050-w","article-title":"A\u00a0systematic review of meta-analyses assessing the validity of tumour response endpoints as surrogates for progression-free or overall survival in cancer","volume":"123","author":"Cooper","year":"2020","journal-title":"Brit J Cancer"},{"key":"10.1016\/j.jval.2025.01.005_bib31","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2022.04.027","article-title":"Disease-free survival as a surrogate endpoint for overall survival in adults with resectable esophageal or gastroesophageal junction cancer: a correlation meta-analysis","volume":"170","author":"Ajani","year":"2022","journal-title":"Eur J Cancer"},{"issue":"90","key":"10.1016\/j.jval.2025.01.005_bib32","first-page":"1","article-title":"Progression-free survival early assessment is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma","volume":"13","author":"Cabibbo","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jval.2025.01.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/EVIDoa2200195","article-title":"Meta-analysis of candidate surrogate end points in advanced prostate cancer","volume":"2","author":"Gharzai","year":"2023","journal-title":"NEJM Evid"},{"issue":"21","key":"10.1016\/j.jval.2025.01.005_bib34","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.3390\/cancers14215391","article-title":"The validity of surrogate endpoints in sub groups of metastatic colorectal cancer patients defined by treatment class and KRAS status","volume":"14","author":"Poad","year":"2022","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.jval.2025.01.005_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/oncolo\/oyac006","article-title":"Surrogacy beyond prognosis: the importance of \u201ctrial-level\u201d surrogacy","volume":"27","author":"Buyse","year":"2022","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.jval.2025.01.005_bib36","article-title":"Searching for potential surrogate endpoints of overall survival in clinical trials for patients with prostate cancer","volume":"4","author":"Maeda","year":"2021","journal-title":"Cancer rep (Hoboken)"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301525000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T22:20:39Z","timestamp":1743027639000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301525000233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1098301525000233"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.005","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Comparison of the Performance of 6 Surrogacy Models, Including Weighted Linear Regression, Meta-Regression, and Bivariate Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}